Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The development of targeted therapies has revolutionized cancer treatment, focusing on specific molecular pathways that drive tumor progression. The Akt (Protein Kinase B) pathway is a central regulator of cell growth, survival, and metabolism, and its hyperactivity is common in many cancers. MK2206 dihydrochloride, a selective allosteric inhibitor of Akt, has become a vital research tool and pharmaceutical intermediate in this domain.
As a dedicated manufacturer of MK2206 dihydrochloride, we provide high-purity material (≥98% Min, CAS 1032350-13-2) crucial for understanding its impact on cancer cells. This compound works by inhibiting Akt1, Akt2, and Akt3, thereby disrupting downstream signaling that promotes cell survival and proliferation. Researchers can buy MK2206 dihydrochloride to explore its effects on various cancer cell lines, observing mechanisms like cell cycle arrest and induction of apoptosis.
The significance of MK2206 dihydrochloride extends to its potential to overcome drug resistance. Studies have shown that it can synergize with conventional chemotherapeutics and other targeted agents, enhancing their efficacy. This makes it a compound of great interest for developing combination treatment strategies. For pharmaceutical companies, securing a reliable supply of this critical intermediate from a trusted supplier in China is essential for their drug development pipelines.
When considering the MK2206 dihydrochloride price, it's important to balance cost with quality assurance. Our commitment to stringent quality control ensures that researchers receive a product that yields consistent and reliable results, ultimately saving time and resources in the long run. We offer competitive pricing for this vital pharmaceutical intermediate, making advanced cancer research more accessible.
The use of MK2206 dihydrochloride in preclinical studies is extensive. It aids in validating Akt as a therapeutic target and in screening for new drug candidates that modulate this pathway. Its well-defined mechanism of action and established safety profile in research settings make it a preferred choice for scientists worldwide.
In conclusion, MK2206 dihydrochloride is a powerful molecule with significant implications for cancer research and therapy development. As a leading MK2206 dihydrochloride manufacturer and supplier, we are committed to supporting scientific progress by providing high-quality, high-purity compounds. We encourage researchers and developers to order MK2206 dihydrochloride from us to advance their critical work in understanding and combating cancer.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
